# Ginkgo BioWorks

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ginkgo-bioworks

- Industry: Biotechnology
- Headquarters: Boston, US
- Website: www.ginkgobioworks.com
- Total disclosed funding: $812M
- Latest round: Series F (May 28, 2020)
- Investors on record: 15

## About

Founded in 2008 and based in Massachusetts, US, Ginkgo BioWorks, Inc. develops and engineers microorganisms for multiple industries, such as food, cosmetics, farming, and pharmaceuticals. The company was founded by Austin Che, Barry Canton, Jason Kelly, Reshma Shetty, and Tom Knight. In May 2020, Ginkgo BioWorks, Inc. raised USD 70 million in series F funding from new investor Illumina, Inc. and in May 2021, Soaring Eagle Acquisition Corp., a special purpose acquisition company, agreed to acquire Ginkgo BioWorks, Inc. 

The company operates a software platform that uses advanced robotic automation, data analytics, and genetic engineering to program and produce living cells like bacteria with industrial applications ranging from cheesemaking to medicine. Ginkgo Bioworks designs, engineers, develops, tests, and licenses microorganisms that can be used by other companies as microbial products for flavors, sweeteners, cosmetic ingredients, crop treatments, and pharmaceuticals. 

After the acquisition by Soaring Eagle Acquisition Corp., the company plans to become a publicly listed company. In 2021, Ginkgo expects to generate USD 150 million in revenue, which is approximately 96% growth compared to 2020.

## Funding rounds

- Series F, May 28, 2020, $70M — General Atlantic, Viking Global Investors, Illumina, Inc.
- Series E, Sep 9, 2019, $290M — T Rowe Price, General Atlantic, Allen & Company, Cascade Investment, iGlobe Partners, Viking Global Investors, Baillie Gifford, Felicis Ventures, Y Combinator, Vast Ventures, DCVC, Awaken Capital, Senator Investment Group
- Series D, Oct 31, 2017, $291M — General Atlantic, Cascade Investment, Viking Global Investors, Y Combinator
- Series C, May 19, 2016, $99M — Allen & Company, Cascade Investment, Viking Global Investors, Baillie Gifford, Y Combinator, Senator Investment Group
- Series B, Jul 8, 2015, $53M — Viking Global Investors, Felicis Ventures, Y Combinator, Awaken Capital
- Series A, Mar 18, 2015, $9M — iGlobe Partners, Felicis Ventures, Vast Ventures, DCVC, Awaken Capital
- Seed, Aug 20, 2014, $0.1M — T Rowe Price, General Atlantic, Y Combinator, TSVC, Senator Investment Group

## Investors

- T Rowe Price (https://capitalatlas.ai/funds/t-rowe-price) — Seed, Series E
- General Atlantic (https://capitalatlas.ai/funds/general-atlantic) — Seed, Series D, Series E, Series F
- Y Combinator (https://capitalatlas.ai/funds/y-combinator) — Seed, Series B, Series C, Series D, Series E
- TSVC (https://capitalatlas.ai/funds/tsvc) — Seed
- Senator Investment Group (https://capitalatlas.ai/funds/senator-investment-group) — Seed, Series C, Series E
- iGlobe Partners (https://capitalatlas.ai/funds/iglobe-partners) — Series A, Series E
- Felicis Ventures (https://capitalatlas.ai/funds/felicis-ventures) — Series A, Series B, Series E
- Vast Ventures (https://capitalatlas.ai/funds/vast-ventures) — Series A, Series E
- DCVC (https://capitalatlas.ai/funds/dcvc) — Series A, Series E
- Awaken Capital (https://capitalatlas.ai/funds/awaken-capital) — Series A, Series B, Series E
- Viking Global Investors (https://capitalatlas.ai/funds/viking-global-investors) — Series B, Series C, Series D, Series E, Series F
- Allen & Company — Series C, Series E
- Cascade Investment — Series C, Series D, Series E
- Baillie Gifford (https://capitalatlas.ai/funds/baillie-gifford) — Series C, Series E
- Illumina, Inc. — Series F